Showing results (211-220 of 1,185) with videos related to
Sort By:
Pageof 119
Nephron. Clinical Practice|September 7, 2013
Fluid balance in patients with acute kidney injury: emerging conceptsMélanie Godin, Josée Bouchard, Ravindra L MehtaNephron. Clinical Practice|September 12, 2013
Long-term treatment with mammalian target of rapamycin inhibitor does not benefit patients with autosomal dominant polycystic kidney disease: a meta-analysisCheng Xue, Bing Dai, Changlin MeiNephron. Clinical Practice|July 27, 2013
Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney diseaseIsmail Kocyigit, Mahmut Ilker Yilmaz, Ozcan Orscelik, et al.Nephron. Clinical Practice|December 30, 2011
Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospectsMing-Yang Chang, Albert C M OngNephron. Clinical Practice|December 14, 2012
Glomerular hyperfiltration and proteinuria in transfusion-independent patients with β-thalassemia intermediaFuad N Ziyadeh, Khaled M Musallam, Naji S Mallat, et al.Nephron. Clinical Practice|December 22, 2012
Circulating angiotensin-converting enzyme 2 activity in kidney transplantation: a longitudinal pilot studyMaría José Soler, Marta Riera, Marta Crespo, et al.Nephron. Clinical Practice|December 5, 2012
Chronic kidney disease in the Arab world: a call for actionYoussef M K Farag, Jameela A Kari, Ajay K SinghNephron. Clinical Practice|December 5, 2012
Evolving spectrum of HIV-associated nephropathySalman Ahmed, Luan Truong, Garabed Eknoyan, et al.Nephron. Clinical Practice|December 11, 2012
Risk in dosing regimens for 25-OH vitamin D supplementation in chronic haemodialysis patientsM Albalate, C de la Piedra, A Ortiz, et al.Nephron. Clinical Practice|August 8, 2013
How robust is the 'surprise question' in predicting short-term mortality risk in haemodialysis patients?Maria Da Silva Gane, Andreas Braun, Dave Stott, et al.Pageof 119